https://www.selleckchem.com/pr....oducts/sovleplenib-h
IONS This proof of principle study for rare diseases confirms the importance of database, allowing data management and analysis, which can be used to predict more effective treatments.BACKGROUND With the gradual unveiling of tumour heterogeneity, cancer stem cells (CSCs) are now being considered the initial component of tumour initiation. However, the mechanisms of the growth and maintenance of breast cancer (BRCA) stem cells are still unknown. METHODS To explore the crucial genes modulating BRCA stemness characteristics, w
Like
Comment
Share
